Form 4: Artivion SVP, General Counsel Jean F. Holloway Reports Stock Transactions
SEC Form 4 Filing
Jean F. Holloway, SVP and General Counsel of Artivion, Inc., reports the sale of 18,020 shares of common stock and the exercise of stock options for 19,092 shares.
Summary
- On March 11, 2025, Jean F. Holloway, SVP and General Counsel of Artivion, Inc., executed transactions involving the company's stock.
- Holloway exercised stock options to acquire 19,092 shares of common stock at an exercise price of $21.55.
- Concurrently, Holloway sold 18,020 shares of common stock at a weighted average price of $23.6132, with prices ranging from $23.220 to $23.895.
- These transactions were conducted under a pre-arranged 10b5-1 trading plan adopted on August 30, 2024.
- Following these transactions, Holloway directly owns 197,184 shares of Artivion common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily indicate a broader trend within the medical device industry.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 03/12/2019 | First exercisable date of stock options |
| 08/30/2024 | Date of adoption of 10b5-1 trading plan |
| 03/11/2025 | Date of stock option exercise and stock sale |
| 03/12/2025 | Signature date of the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.